APA

Holcakova J., Tomasec P., Bugert J. J., Wang E. C., Wilkinson G. W., Hrstka R., Krystof V., Strnad M. & Vojtesek B. (20100303). The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties. : Antiviral chemistry & chemotherapy.

Chicago

Holcakova Jitka, Tomasec Peter, Bugert Joachim J, Wang Eddie Cy, Wilkinson Gavin Wg, Hrstka Roman, Krystof Vladimir, Strnad Miroslav and Vojtesek Borivoj. 20100303. The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties. : Antiviral chemistry & chemotherapy.

Harvard

Holcakova J., Tomasec P., Bugert J. J., Wang E. C., Wilkinson G. W., Hrstka R., Krystof V., Strnad M. and Vojtesek B. (20100303). The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties. : Antiviral chemistry & chemotherapy.

MLA

Holcakova Jitka, Tomasec Peter, Bugert Joachim J, Wang Eddie Cy, Wilkinson Gavin Wg, Hrstka Roman, Krystof Vladimir, Strnad Miroslav and Vojtesek Borivoj. The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties. : Antiviral chemistry & chemotherapy. 20100303.